High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α

FASEB Journal

Volumn 28, Issue 1, 2014, Pages 206-217

  Tan, Joanne T M ^a,b   G Prosser, Hamish C ^a,b   Vanags, Laura Z ^a,b   Monger, Steven A ^a   Ng, Martin K C ^a,b,c   Bursill, Christina A ^a,b  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Endothelial cells; Phosphatidylinositol 3 kinase; PI3K Akt pathway; Prolyl hydroxylase domain proteins; Scavenger receptor BI; Siah ubiquitin ligases

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE 1; PROLYL HYDROXYLASE 2; PROLYL HYDROXYLASE 3; PROTEIN KINASE B; SCAVENGER RECEPTOR BI; SHORT HAIRPIN RNA; SIAH1 PROTEIN; SIAH2 PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE; NUCLEAR PROTEIN; SEVEN IN ABSENTIA PROTEINS; UBIQUITIN PROTEIN LIGASE;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ENDOTHELIAL CELL; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; CELL CULTURE; CELL HYPOXIA; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; PI3K/AKT PATHWAY; PROLYL HYDROXYLASE DOMAIN PROTEINS; SIAH UBIQUITIN LIGASES;

ENDOTHELIAL CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PI3K/AKT PATHWAY; PROLYL HYDROXYLASE DOMAIN PROTEINS; SCAVENGER RECEPTOR BI; SIAH UBIQUITIN LIGASES;

CELL HYPOXIA; CELLS, CULTURED; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR-PROLINE DIOXYGENASES; LIPOPROTEINS, HDL; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; UBIQUITIN-PROTEIN LIGASES;

EID: 84894546587     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-233874     Document Type: Article

References (45)

1. Folkman, J., and Shing, Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10931-10934
2. Lee, S. H., Wolf, P. L., Escudero, R., Deutsch, R., Jamieson, S. W., and Thistlethwaite, P. A. (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342, 626-633
3. Ware, J. A., and Simons, M. (1997) Angiogenesis in ischemic heart disease. Nat. Med. 3, 158-164
4. Bruick, R. K. (2003) Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 17, 2614-2623
5. Huang, L. E., and Bunn, H. F. (2003) Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 278, 19575-19578
6. Semenza, G. L. (2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19, 176-182
7. Appelhoff, R. J., Tian, Y. M., Raval, R. R., Turley, H., Harris, A. L., Pugh, C. W., Ratcliffe, P. J., and Gleadle, J. M. (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465
8. Nakayama, K., Qi, J., and Ronai, Z. (2009) The ubiquitin ligase Siah2 and the hypoxia response. Mol. Cancer Res. 7, 443-451
9. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian, Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P. H., Pugh, C. W., Schofield, C. J., and Ratcliffe, P. J. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54
10. Bruick, R. K., and McKnight, S. L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340
11. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., von Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J., Maxwell, P. H., Pugh, C. W., and Ratcliffe, P. J. (2001) Targeting of HIF- to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472
12. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., and Kaelin, W. G., Jr. (2001) HIF targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464-468
13. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., and Ratcliffe, P. J. (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206
14. Nakayama, K., Frew, I. J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P. B., Bowtell, D. D., and Ronai, Z. (2004) Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952
15. Gordon, D. J., and Rifkind, B. M. (1989) High-density lipoprotein- the clinical implications of recent studies. N. Engl. J. Med. 321, 1311-1316
16. Sumi, M., Sata, M., Miura, S., Rye, K. A., Toya, N., Kanaoka, Y., Yanaga, K., Ohki, T., Saku, K., and Nagai, R. (2007) Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 27, 813-818
17. Feng, Y., van Eck, M., Van Craeyveld, E., Jacobs, F., Carlier, V., Van Linthout, S., Erdel, M., Tjwa, M., and De Geest, B. (2009) Critical role of scavenger receptor-BI-expressing bone marrowderived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 113, 755-764
18. Seetharam, D., Mineo, C., Gormley, A. K., Gibson, L. L., Vongpatanasin, W., Chambliss, K. L., Hahner, L. D., Cummings, M. L., Kitchens, R. L., Marcel, Y. L., Rader, D. J., and Shaul, P. W. (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ. Res. 98, 63-72
19. Feng, Y., Jacobs, F., Van Craeyveld, E., Brunaud, C., Snoeys, J., Tjwa, M., Van Linthout, S., and De Geest, B. (2008) Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28, 278-283
20. Mineo, C., and Shaul, P. W. (2007) Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair. Trends Cardiovasc. Med. 17, 156-161
21. Miura, S., Fujino, M., Matsuo, Y., Kawamura, A., Tanigawa, H., Nishikawa, H., and Saku, K. (2003) High density lipoproteininduced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23, 802-808
22. Weisweiler, P. (1987) Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. Clin. Chim. Acta 169, 249-254
23. Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., and Trono, D. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880
24. Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., and Naldini, L. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471
25. Aragones, J., Schneider, M., Van Geyte, K., Fraisl, P., Dresselaers, T., Mazzone, M., Dirkx, R., Zacchigna, S., Lemieux, H., Jeoung, N. H., Lambrechts, D., Bishop, T., Lafuste, P., Diez-Juan, A., Harten, S. K., Van Noten, P., De Bock, K., Willam, C., Tjwa, M., Grosfeld, A., Navet, R., Moons, L., Vandendriessche, T., Deroose, C., Wijeyekoon, B., Nuyts, J., Jordan, B., Silasi-Mansat, R., Lupu, F., Dewerchin, M., Pugh, C., Salmon, P., Mortelmans, L., Gallez, B., Gorus, F., Buyse, J., Sluse, F., Harris, R. A., Gnaiger, E., Hespel, P., Van Hecke, P., Schuit, F., Van Veldhoven, P., Ratcliffe, P., Baes, M., Maxwell, P., and Carmeliet, P. (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40, 170-180
26. Al-Khalili, F., Svane, B., Janszky, I., Ryden, L., Orth-Gomer, K., and Schenck-Gustafsson, K. (2002) Significant predictors of poor prognosis in women aged 65 years hospitalized for an acute coronary event. J. Intern. Med. 252, 561-569
27. Berge, K. G., Canner, P. L., and Hainline, A., Jr. (1982) High-density lipoprotein cholesterol and prognosis after myocardial infarction. Circulation 66, 1176-1178
28. van der Vorst, E. P., Vanags, L. Z., Dunn, L. L., Prosser, H. C., Rye, K. A., and Bursill, C. A. (2013) High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells. FASEB J. 27, 1413-1425
29. Fox, S. B., Generali, D., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., Mele, T., Dogliotti, L., Bottini, A., and Harris, A. L. (2011) The prolyl hydroxylase enzymes are positively associated with hypoxiainducible factor-1 and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen. Breast Cancer Res. 13, R16
30. Nakayama, K. (2009) Cellular signal transduction of the hypoxia response. J. Biochem. 146, 757-765
31. Coulon, C., Georgiadou, M., Roncal, C., De Bock, K., Langenberg, T., and Carmeliet, P. (2010) From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/ hypoxia-inducible factor oxygen-sensing machinery. Arterioscler. Thromb. Vasc. Biol. 30, 2331-2336
32. Prosser, H. C. (2012) Abstract 392: high-density lipoproteins beneficially regulate angiogenesis. Arterioscler. Thromb. Vasc. Biol. 32, A392
33. Yang, X. M., Wang, Y. S., Zhang, J., Li, Y., Xu, J. F., Zhu, J., Zhao, W., Chu, D. K., and Wiedemann, P. (2009) Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1 and VEGF in laser-induced rat choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 50, 1873-1879
34. Zhang, Q., Yin, H., Liu, P., Zhang, H., and She, M. (2010) Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway. Exp. Biol. Med. (Maywood) 235, 1082-1092
35. Dachs, G. U., and Tozer, G. M. (2000) Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer 36, 1649-1660
36. Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., and Johnson, R. S. (2000) Hypoxia-inducible factor-1 is a positive factor in solid tumor growth. Cancer Res. 60, 4010-4015
37. Tsuzuki, Y., Fukumura, D., Oosthuyse, B., Koike, C., Carmeliet, P., and Jain, R. K. (2000) Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1- hypoxia response element VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. 60, 6248-6252
38. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613
39. Yao, Y., Shao, E. S., Jumabay, M., Shahbazian, A., Ji, S., and Bostrom, K. I. (2008) High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2. Arterioscler. Thromb. Vasc. Biol. 28, 2266-2274
40. Jenkins, P. J., Harper, R. W., and Nestel, P. J. (1978) Severity of coronary atherosclerosis related to lipoprotein concentration. Br. Med. J. 2, 388-391
41. Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., Halpern, S., Crowe, T., Blankenship, J. C., and Kerensky, R. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290, 2292-2300
42. Tardif, J. C., Gregoire, J., L'Allier, P. L., Ibrahim, R., Lesperance, J., Heinonen, T. M., Kouz, S., Berry, C., Basser, R., Lavoie, M. A., Guertin, M. C., and Rodes-Cabau, J. (2007) Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297, 1675-1682
43. Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J. C., Waters, D. D., Shear, C. L., Revkin, J. H., Buhr, K. A., Fisher, M. R., Tall, A. R., and Brewer, B. (2007) Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357, 2109-2122
44. Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., Leitersdorf, E., McMurray, J. J., Mundl, H., Nicholls, S. J., Shah, P. K., Tardif, J. C., and Wright, R. S. (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med. 367, 2089-2099
45. Boden, W. E., Probstfield, J. L., Anderson, T., Chaitman, B. R., Desvignes-Nickens, P., Koprowicz, K., McBride, R., Teo, K., and Weintraub, W. (2011) Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365, 2255-2267